Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET).

Giuseppe Lamberti,Natalie Prinzi,Alberto Bongiovanni,Mariangela Torniai,Elisa Andrini,Dario de Biase,Deborah Malvi,Mirta Mosca,Rossana Berardi,Toni Ibrahim,Sara Pusceddu,Davide Campana

Diagnostics (Basel, Switzerland)（2023）

引用 0|浏览34

暂无评分

摘要

FOLFOX/XELOX chemotherapy is active as the first-line treatment of patients with G3 GEP-NET. The mutational landscape of G3 NET is more similar to well-differentiated NETs than NECs.

查看译文

关键词

NET,G3,FOLFOX,XELOX,CAPTEM,NGS

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要